Xaira Therapeutics

AI-powered breakthroughs in medicine.

Edited:

Visit Website

📋 Overview of Xaira Therapeutics

Founding Year

2023

Estimated Funding

$0000

Size

$0000

Locations

San Francisco

Primary Industry

Biotechnology, Industry

📙 About Xaira Therapeutics

Xaira Therapeutics, founded in 2023 by David Baker, is a biotechnology company leveraging artificial intelligence to revolutionize drug discovery and development. The company integrates robust product development, biological and clinical data generation, and advanced AI methodologies to streamline the drug development process.

💰 Recent Investors of Xaira Therapeutics

ARCH Venture Partners, Byers Capital, Investor

🔁 Companies Similar to Xaira Therapeutics

Genesis Therapeutics View Profile →

Genesis Therapeutics

Revolutionizes drug discovery with AI.

Burlingame

Genesis Therapeutics View Profile →

Genesis Therapeutics

Revolutionizes drug discovery with AI.

Burlingame

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.